Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1994; 23:1066-1070
© 1994 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, D.
Right arrow Articles by Sacks, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, D.
Right arrow Articles by Sacks, J

Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina

DA Morrison, ST Crowley, G Veerakul, CC Barbiere, F Grover, and J Sacks

Cardiology Section, Denver Department of Veterans Affairs Medical Center, Colorado.

OBJECTIVES. We attempted to answer the question, Is balloon angioplasty a reasonable alternative to repeat coronary artery bypass graft surgery in patients with previous coronary bypass graft surgery, medically refractory unstable angina and vein graft lesions? BACKGROUND. Patients with medically refractory unstable angina need revascularization. Patients with previous coronary artery bypass graft surgery and medically refractory angina are at "high risk" for adverse outcomes with repeat coronary bypass graft surgery. Conversely, patients with angioplasty of old vein grafts are also at "high risk" for adverse outcomes. METHODS. Balloon angioplasty of 89 lesions in saphenous vein grafts was performed in 75 consecutive patients with medically refractory unstable angina. Of these 75 patients, 24 (32%) had myocardial infarct within 30 days, 23 (31%) had left ventricular ejection fraction < 0.35, and 50 (67%) had major comorbidity. Patients underwent standard balloon angioplasty with aggressive use of intravenous and intracoronary heparin, urokinase, nitroglycerin, oral aspirin, calcium channel blocking agents and coumadin. RESULTS. Angiographic success (reduction of stenosis < or = 50% without major complication) was seen in 84 of 89 lesions. Clinical success (angiographic success plus hospital discharge without major complication) was seen in 70 of 75 patients. During index hospitalization, two patients (3%) died, two (3%) had nonfatal infarcts, and one (1%) had emergency reoperation (coronary bypass graft surgery). In late follow up (3 to 66 months), 14 (20%) patients were lost to follow-up, 17 (23%) had repeat percutaneous transluminal coronary angioplasty, 2 (3%) had late bypass graft reoperation, 18 (25%) had late death, and 1 (< 1%) had a heart transplant. Of the 41 patients alive after one or more angioplasties, 25 have little or no angina, and 16 have occasional or more angina. We compared long-term survival rate in these 75 patients with a cohort of patients with high risk, unstable angina from the Veterans Affairs Surgical Registry (2,570 patients). The 30-day survival rate was better in patients with coronary angioplasty (97% vs. 92%, p < 0.05), but by 6 months there was no difference, and by 5 years a trend toward a higher survival rate with coronary artery bypass graft surgery was seen. CONCLUSIONS. Balloon angioplasty of saphenous vein grafts with aggressive adjunctive pharmacotherapy is a reasonable alternative to repeat coronary bypass graft surgery in patients with medically refractory unstable angina, previous coronary bypass graft surgery and saphenous vein narrowing.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
L. Ge, I. Iakovou, G. M. Sangiorgi, A. Chieffo, G. Melzi, J. Cosgrave, M. Montorfano, I. Michev, F. Airoldi, M. Carlino, et al.
Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. A. Ribeiro, K. Scavetta, C. Oh, M. Al-Zaibag, K. R. Jutzy, R. Caldron, and R. J. Marsa
Long-term Clinical Results After Stent Implantation in Old Obstructed Saphenous Vein Grafts
Chest, September 1, 2000; 118(3): 750 - 755.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K. Scavetta, C. Oh, R. Caldron, T. Abdel-Dayem, M. Al-Zaibag, K. R. Jutzy, R. J. Marsa, M. Sjolander, and P. A. Ribeiro
Results of Saphenous Vein Graft Stent Implantation: Single Center Results from Use of Oversized Balloon Catheters
Angiology, November 1, 1999; 50(11): 891 - 899.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
V. Mathew, D. E. Grill, C. G. Scott, J. A. Grantham, H. H. Ting, K. N. Garratt, and D. R. Holmes Jr.
The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1163 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al.
ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1756 - 1824.
[Full Text] [PDF]


Home page
CirculationHome page
J. A. Silva, A. Escobar, T. J. Collins, S. R. Ramee, and C. J. White
Unstable Angina : A Comparison of Angioscopic Findings Between Diabetic and Nondiabetic Patients
Circulation, October 1, 1995; 92(7): 1731 - 1736.
[Abstract] [Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement